Researchers Outline Pathological Mechanisms, Potential Therapeutic Targets in PAH
Dr Stephen Silberstein on the Next Steps for Anti-CGRP Therapies
New ACC Pathway in Atrial Fibrillation Calls for Limiting Aspirin
Top 5 Most-Read COVID-19 News of 2020
Self-Care Intervention Fails to Significantly Improve Outcomes Among Patients With Heart Failure
Study Finds Patients With Parkinson Disease at Greater Risk of Death by Suicide
Patients With Systemic Lupus Erythematosus Have Higher Cardiometabolic Risk for CVD
What We’re Reading: Panel Recommends Next Vaccine Recipients; Package Addresses Surprise Medical Billing; Tennessee Virus Cases Surge
“Sore Eyes” Reported as Most Significant Ocular Symptom of COVID-19
Rolling Submission Begins for BLA on Cilta-Cel in R/R Multiple Myeloma
Top 5 Most-Read HIV Articles of 2020
Top 5 Most-Read Breast Cancer Articles of 2020
As Reimbursement for Mohs Surgery Increased, So Did Use, Study Finds
Podcast: This Week in Managed Care—First COVID-19 Vaccine Shipments and Other Health News
MBSR Reduced Pain Perception in Patients With Migraine
SPMS Drug Linked to Improved Cognition Processing Speed, Study Says
What Are Pulmonary Function Testing Options in Neuromuscular Diseases Like SMA?
Newly Studied Neurological Impact of Polio Could Have Implications for SMA
Pandemic-Related Social Isolation Linked With Worsening Symptom Severity, Quality of Life in Parkinson Disease
Subgroup Analysis Confirms Safety, Efficacy of Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
Gene Expression Signatures Linked With Response to HMA Treatment in Patients With MDS
Study Finds Vascepa Reduces Patient-Reported COVID-19 Symptoms
Researchers Discuss Closing Racial Gaps in ESKD Incidence Rates
FDA Signs Off on EUA for Moderna's COVID-19 Vaccine
Cardiovascular Complications in Patients With Diabetes Drop in South Korea, Study Finds
Sarilumab Shows Greater Improvements in QoL for Patients With RA and High Levels of IL-6
Duplex Sequencing Technology Detects Early Carcinogen-Caused Mutagenesis
Dr Bradley Monk Discusses PARP Inhibitor Reimbursement
Contributor: Coping With Insomnia During COVID-19
AJMC® in the Press, December 18, 2020